salvexin + b
schering-plough animal health limited - salmonella hindmarsh cn 5989 (inactivated); salmonella bovis morbificans cn1412 (inactivated); salmonella typhimurium cn5988 (inactivated); salmonella brandenburg 1br 3684 (inactivated); salmonella typhimurium cn6141 (inactivated) - salmonella hindmarsh cn 5989 (inactivated) 0 vaccine; salmonella bovis morbificans cn1412 (inactivated) 0 vaccine; salmonella typhimurium cn5988 (inactivated) 0 vaccine; salmonella brandenburg 1br 3684 (inactivated) 0 vaccine; salmonella typhimurium cn6141 (inactivated) 0 vaccine - vaccine
avipro megan vac 1
pacificvet limited - salmonella typhimurium cn5988 (inactivated) - salmonella typhimurium cn5988 (inactivated) 0 m cfu/ml - vaccine
biodose st
pacificvet limited - salmonella typhimurium strain 421/125 - salmonella typhimurium strain 421/125 0 vaccine - vaccine
salmoporc lyophilisate and solvent for suspension for injection for pigs
idt biologika gmbh - salmonella typhimurium mutant, strain 421/125 - lyophilisate and solvent for suspension for injection - . - salmonella
salmoporc lyophilisate for oral suspension for pigs
idt biologika gmbh - salmonella typhimurium mutant, strain 421/125 - lyophilisate for oral suspension - . - salmonella
biosuis salm emulsion for injection for pigs
bioveta, a.s. - salmonella enterica subsp. enterica sv. typhimurium (wild type, fagotype: dt104); salmonella enterica subsp. enterica sv. derby (wild type, pfge type: de1); salmonella enterica subsp. enterica sv. infantis (wild type) - emulsion for injection - . - salmonella
vivotif- salmonella typhi ty21a capsule, coated
a-s medication solutions - salmonella typhi ty21a live antigen (unii: 0mzi008m96) (salmonella typhi ty21a live antigen - unii:0mzi008m96) - vivotif (typhoid vaccine live oral ty21a) is indicated for immunization of adults and children greater than 6 years of age against disease caused by salmonella typhi . routine typhoid vaccination is not recommended in the united states of america. selective immunization against typhoid fever is recommended for the following groups: 1) travelers to areas in which there is a recognized risk of exposure to s. typhi , 2) persons with intimate exposure (e.g. household contact) to a s. typhi carrier, and 3) microbiology laboratorians who work frequently with s. typhi (7). there is no evidence to support the use of typhoid vaccine to control common source outbreaks, disease following natural disasters or in persons attending rural summer camps. not all recipients of vivotif will be fully protected against typhoid fever. vaccinated individuals should continue to take personal precautions against exposure to typhoid organisms. the vaccine will not afford protection against species of salmonella other than salm
salmoporc lyophilisate and solvent for suspension for injection for pigs
ceva santé animale - salmonella typhimurium mutant, strain 421/125 - lyophilisate and solvent for suspension for injection - . - salmonella
salmoporc lyophilisate for oral suspension for pigs
ceva santé animale - salmonella typhimurium mutant, strain 421/125 - lyophilisate for oral suspension - . - salmonella
nobilis sg 9r formulation: each 0.2 ml (dose) contains: salmonella gallinarum (strain 9r) cfu - colony forming unit > 2 x 107 cfu freeze-dried powder for injection (sc)
msd animal health (phils.), inc. - live attenuated salmonella gallinarum vaccine (vet.) - freeze-dried powder for injection (sc) - formulation: each 0.2 ml (dose) contains: salmonella gallinarum (strain 9r) cfu - colony forming unit > 2 x 107 cfu